awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26783253-8B8147BB-1EEA-4536-9EDF-DE8E92F95B2C
Q26783253-8B8147BB-1EEA-4536-9EDF-DE8E92F95B2C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26783253-8B8147BB-1EEA-4536-9EDF-DE8E92F95B2C
Efficacy, safety, and patient acceptability of elvitegravir/cobicistat/emtricitabine/tenofovir in the treatment of HIV/AIDS
P2860
Q26783253-8B8147BB-1EEA-4536-9EDF-DE8E92F95B2C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26783253-8B8147BB-1EEA-4536-9EDF-DE8E92F95B2C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
73895b0a0107e37f2a105ffe1462e843b9857ff9
P2860
Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week res